Article Text

Download PDFPDF

OHP-038 Evaluation of Quality of Life in Patients with Multiple Sclerosis
  1. MC Izquierdo Navarro1,
  2. C Matallana Martin1,
  3. V Martínez Santana1,
  4. MA Calleja Hernandez2,
  5. AM López González1,
  6. MT Sánchez Sánchez1
  1. 1Hospital Clínico Universitario, Pharmacy Department, Valladolid, Spain
  2. 2Hospital Vírgen de la Nieves, Pharmacy Department, Granada, Spain


Background Several studies have evaluated quality of life (QoL) by filling in the EuroQoL-5D..In most of them, it is found that the two dimensions of EuroQoL-5D most associated with a poor QoL are pain/discomfort and anxiety/depression.

Purpose To find the dimensions of EuroQoL-5D that are more frequently associated with QoL in patients diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS).

Materials and Methods Observational, four-month, cross-sectional study (January–April 2012) to assess QoL in patients diagnosed with RRMS.

Sex, age and Expanded Disability Status Scale (EDSS) were gathered from Pacientes Externos (Farmatools programme 2.4 version).

Patients who filled in the EuroQoL-5D returned it to the pharmacy service.

Results 84 patients were included; 62 completed the questionnaire.

Mean age was 36.94 ± 8.67. 65.47% of patients were women, 34.52% were men. The mean EDSS was 2.03 ± 1.50.

The survey results of the questionnaire broken down by items were:

The mean value obtained in the questionnaire was 0.71 ± 0.19.

Abstract OHP-038 Table 1

Conclusions As has been shown in previous studies, the two dimensions of EuroQoL-5D that most affected the QoL were pain/discomfort and anxiety/depression.

No conflict of interest.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.